HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH)
Clinical trials for HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH) explained in plain language.
Never miss a new study
Get alerted when new HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH) trials appear
Sign up with your email to follow new studies for HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot takes aim at genetic high cholesterol in major trial
Disease control Not yet recruitingThis study tests an injection called SYH2053 in 135 adults with heterozygous familial hypercholesterolemia (HeFH), an inherited condition causing very high cholesterol and heart disease risk. Participants must already be on a stable statin and low-fat diet. The main goal is to se…
Matched conditions: HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH)
Phase: PHASE3 • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New shot could tame inherited high cholesterol in phase 3 trial
Disease control Not yet recruitingThis study tests a new medicine called QLC7401 for people with a genetic condition that causes very high cholesterol (heterozygous familial hypercholesterolemia). About 120 adults who are already on cholesterol-lowering drugs will receive either QLC7401 or a placebo as a shot. Th…
Matched conditions: HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH)
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Heart scan study to watch artery blockages in High-Risk patients
Knowledge-focused Not yet recruitingThis study follows 300 adults with a genetic condition that causes very high cholesterol (familial hypercholesterolemia) to see how their heart arteries change over 5 years. Participants will get a special CT scan to measure blockages and plaque buildup. The goal is to learn more…
Matched conditions: HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH)
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 08, 2026 12:03 UTC